Prothena's Partner Bristol Myers Squibb Obtains Fast Track Designation from the U.S. FDA for BMS-986446 , an Anti-MTBR-Tau-Targeting Antibody, for the Treatment of Alzheimer's Disease
First Diamond Drill Program Commences at Nobel's Flagship Cuprita Copper Project, Antofagasta Region, Chile
